X0508 4 2024-02-08 0001781174 Acrivon Therapeutics, Inc. ACRV 0001279281 Magovcevic-Liebisch Ivana C/O ACRIVON THERAPEUTICS, INC. 480 ARSENAL WAY, SUITE 100 WATERTOWN MA 02472 true false Stock Option (Right to Buy) 3.54 2024-02-08 4 A 0 32500 0 A 2034-02-07 Common Stock 32500 32500 D The shares subject to the option shall vest in 36 substantially equal monthly installments beginning on February 8, 2024 ("Vesting Commencement Date"), such that all shares are fully vested on the third anniversary of the Vesting Commencement Date, in each case subject to the Reporting Person's continuous service through each such vesting date. /s/ Rasmus Holm-Jorgensen, Attorney-in-Fact 2024-02-09